α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation

Takashi Ichiyama, Hui Zhao, Anna Catania, Susumu Furukawa, James M. Lipton

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

The neuropeptide α-melanocyte-stimulating hormone (α-MSH) modulates production of proinflammatory cytokines in brain tissue and in peripheral inflammatory cells. Transcription of the genes for these proinflammatory cytokines is regulated by the nuclear factor κB (NF-κB). NF-κB is also activated by proinflammatory cytokines. Degradation of the cytoplasmic inhibitor IκBα protein results in activation of NF-κB. Because of increasing evidence that NF-κB is involved in brain injury and inflammation and neurodegenerative disease, we examined whether α-MSH inhibits activation of NF-κB and limits degradation of IκBα protein induced by lipopolysaccharide (LPS) in human glioma cells (A-172) and in mouse brain. Electrophoretic mobility shift assays of nuclear extracts from A-172 cells and whole mouse brains stimulated with LPS revealed that α-MSH does suppress NF-κB activation. Western blot analysis demonstrated that α-MSH preserved expression of IκBα protein in vitro (glioma cells) and in vivo (brain tissue). Chloramphenicol acetyltransferase assay indicated that α-MSH suppresses NF-κB-dependent reporter gene expression induced by LPS in A-172 cells. The findings are consistent with the possibility that the anti- inflammatory action of α-MSH in CNS inflammation occurs via modulation of NF-κB activation by peptide-induced inhibition of degradation of IκBα protein.

Original languageEnglish
Pages (from-to)359-365
Number of pages7
JournalExperimental Neurology
Volume157
Issue number2
DOIs
Publication statusPublished - Jun 1999

Fingerprint

Melanocyte-Stimulating Hormones
Encephalitis
Glioma
Lipopolysaccharides
Brain
Cytokines
Proteolysis
Chloramphenicol O-Acetyltransferase
Electrophoretic Mobility Shift Assay
Neuropeptides
Reporter Genes
Neurodegenerative Diseases
Brain Injuries
Proteins
Anti-Inflammatory Agents
Western Blotting
Inflammation
Gene Expression
Peptides
Genes

Keywords

  • α-Melanocyte-stimulating hormone
  • Astrocyte
  • Inflammation
  • Lipopolysaccharide
  • NF-κB; IκBα

ASJC Scopus subject areas

  • Neurology
  • Neuroscience(all)

Cite this

α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation. / Ichiyama, Takashi; Zhao, Hui; Catania, Anna; Furukawa, Susumu; Lipton, James M.

In: Experimental Neurology, Vol. 157, No. 2, 06.1999, p. 359-365.

Research output: Contribution to journalArticle

Ichiyama, Takashi ; Zhao, Hui ; Catania, Anna ; Furukawa, Susumu ; Lipton, James M. / α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation. In: Experimental Neurology. 1999 ; Vol. 157, No. 2. pp. 359-365.
@article{7c3a3a6f48b84c65ac1e979e30072beb,
title = "α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation",
abstract = "The neuropeptide α-melanocyte-stimulating hormone (α-MSH) modulates production of proinflammatory cytokines in brain tissue and in peripheral inflammatory cells. Transcription of the genes for these proinflammatory cytokines is regulated by the nuclear factor κB (NF-κB). NF-κB is also activated by proinflammatory cytokines. Degradation of the cytoplasmic inhibitor IκBα protein results in activation of NF-κB. Because of increasing evidence that NF-κB is involved in brain injury and inflammation and neurodegenerative disease, we examined whether α-MSH inhibits activation of NF-κB and limits degradation of IκBα protein induced by lipopolysaccharide (LPS) in human glioma cells (A-172) and in mouse brain. Electrophoretic mobility shift assays of nuclear extracts from A-172 cells and whole mouse brains stimulated with LPS revealed that α-MSH does suppress NF-κB activation. Western blot analysis demonstrated that α-MSH preserved expression of IκBα protein in vitro (glioma cells) and in vivo (brain tissue). Chloramphenicol acetyltransferase assay indicated that α-MSH suppresses NF-κB-dependent reporter gene expression induced by LPS in A-172 cells. The findings are consistent with the possibility that the anti- inflammatory action of α-MSH in CNS inflammation occurs via modulation of NF-κB activation by peptide-induced inhibition of degradation of IκBα protein.",
keywords = "α-Melanocyte-stimulating hormone, Astrocyte, Inflammation, Lipopolysaccharide, NF-κB; IκBα",
author = "Takashi Ichiyama and Hui Zhao and Anna Catania and Susumu Furukawa and Lipton, {James M.}",
year = "1999",
month = "6",
doi = "10.1006/exnr.1999.7064",
language = "English",
volume = "157",
pages = "359--365",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - α-Melanocyte-stimulating hormone inhibits NF-κB activation and IκBα degradation in human glioma cells and in experimental brain inflammation

AU - Ichiyama, Takashi

AU - Zhao, Hui

AU - Catania, Anna

AU - Furukawa, Susumu

AU - Lipton, James M.

PY - 1999/6

Y1 - 1999/6

N2 - The neuropeptide α-melanocyte-stimulating hormone (α-MSH) modulates production of proinflammatory cytokines in brain tissue and in peripheral inflammatory cells. Transcription of the genes for these proinflammatory cytokines is regulated by the nuclear factor κB (NF-κB). NF-κB is also activated by proinflammatory cytokines. Degradation of the cytoplasmic inhibitor IκBα protein results in activation of NF-κB. Because of increasing evidence that NF-κB is involved in brain injury and inflammation and neurodegenerative disease, we examined whether α-MSH inhibits activation of NF-κB and limits degradation of IκBα protein induced by lipopolysaccharide (LPS) in human glioma cells (A-172) and in mouse brain. Electrophoretic mobility shift assays of nuclear extracts from A-172 cells and whole mouse brains stimulated with LPS revealed that α-MSH does suppress NF-κB activation. Western blot analysis demonstrated that α-MSH preserved expression of IκBα protein in vitro (glioma cells) and in vivo (brain tissue). Chloramphenicol acetyltransferase assay indicated that α-MSH suppresses NF-κB-dependent reporter gene expression induced by LPS in A-172 cells. The findings are consistent with the possibility that the anti- inflammatory action of α-MSH in CNS inflammation occurs via modulation of NF-κB activation by peptide-induced inhibition of degradation of IκBα protein.

AB - The neuropeptide α-melanocyte-stimulating hormone (α-MSH) modulates production of proinflammatory cytokines in brain tissue and in peripheral inflammatory cells. Transcription of the genes for these proinflammatory cytokines is regulated by the nuclear factor κB (NF-κB). NF-κB is also activated by proinflammatory cytokines. Degradation of the cytoplasmic inhibitor IκBα protein results in activation of NF-κB. Because of increasing evidence that NF-κB is involved in brain injury and inflammation and neurodegenerative disease, we examined whether α-MSH inhibits activation of NF-κB and limits degradation of IκBα protein induced by lipopolysaccharide (LPS) in human glioma cells (A-172) and in mouse brain. Electrophoretic mobility shift assays of nuclear extracts from A-172 cells and whole mouse brains stimulated with LPS revealed that α-MSH does suppress NF-κB activation. Western blot analysis demonstrated that α-MSH preserved expression of IκBα protein in vitro (glioma cells) and in vivo (brain tissue). Chloramphenicol acetyltransferase assay indicated that α-MSH suppresses NF-κB-dependent reporter gene expression induced by LPS in A-172 cells. The findings are consistent with the possibility that the anti- inflammatory action of α-MSH in CNS inflammation occurs via modulation of NF-κB activation by peptide-induced inhibition of degradation of IκBα protein.

KW - α-Melanocyte-stimulating hormone

KW - Astrocyte

KW - Inflammation

KW - Lipopolysaccharide

KW - NF-κB; IκBα

UR - http://www.scopus.com/inward/record.url?scp=0033050644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033050644&partnerID=8YFLogxK

U2 - 10.1006/exnr.1999.7064

DO - 10.1006/exnr.1999.7064

M3 - Article

VL - 157

SP - 359

EP - 365

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 2

ER -